Related Experiment Video
Updated: Jul 4, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Spotlight on bupropion in major depressive disorder
Sohita Dhillon1, Lily P H Yang, Monique P Curran
1Wolters Kluwer Health Adis, Auckland, New Zealand. demail@adis.co.nz
CNS Drugs
|June 13, 2008
Summary
Bupropion, a dopamine-noradrenaline reuptake inhibitor, effectively treats major depressive disorder (MDD). Newer formulations offer reduced daily dosing frequency for improved patient adherence and tolerability.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Bupropion is a dopamine-noradrenaline (norepinephrine) reuptake inhibitor used as an antidepressant.
- It is available in three oral formulations: immediate release (IR), sustained release (SR), and extended/modified release (XR).
- All formulations demonstrate bioequivalent systemic exposure to bupropion.
Purpose of the Study:
- To evaluate the efficacy and tolerability of different bupropion formulations in treating major depressive disorder (MDD).
- To compare bupropion's effectiveness and side effect profile against other antidepressants like TCAs, SSRIs, and SNRIs.
- To highlight the advantages of newer bupropion formulations regarding dosing frequency.
Main Methods:
- Review of clinical data from placebo-controlled studies evaluating bupropion IR, SR, and XR formulations.
- Comparison of efficacy measures (primary and secondary outcomes) and tolerability profiles.
- Assessment of bupropion's performance against selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs).
Main Results:
- Bupropion IR and SR demonstrated efficacy and good tolerability in MDD treatment, with advantages over some TCAs and SSRIs regarding somnolence and weight gain (IR) and sexual dysfunction (SR).
- Bupropion XR showed efficacy in placebo-controlled studies, with comparable outcomes to escitalopram and venlafaxine XR in some trials, though venlafaxine XR was superior in one study.
- Bupropion XR was generally well-tolerated, showing less sexual dysfunction compared to escitalopram.
Conclusions:
- Bupropion is an effective and well-tolerated treatment option for MDD across its various formulations.
- Sustained-release and extended-release formulations offer the benefit of less frequent administration, potentially improving patient compliance.
- Bupropion presents a favorable alternative, particularly for patients experiencing side effects like somnolence or sexual dysfunction with other antidepressants.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...